PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR METASTATIC UPPER TRACT UROTHELIAL CANCER PATIENTS REFRACTORY TO THE STANDARD CHEMOTHERAPY

被引：0
|
作者：
Suekane, Shigetaka
Ueda, Kousuke
Nishihara, Kiyoaki
Igawa, Tsukasa
Noguchi, Masanori
Sasada, Tetsuro
Yamashita, Takuto
Yutani, Shigeru
Shichijo, Shigeki
Itoh, Kyogo
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.2094
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP78-06
引用
收藏
页码：E1032 / E1033
页数：2
相关论文
共 50 条
  • [1] FEASIBILITY STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR PLATINUM-BASED CHEMOTHERAPY RESISTANT METASTATIC UPPER TRACT UROTHELIAL CARCINOMA PATIENTS
    Suekane, Shigetaka
    Noguchi, Masanori
    Ueda, Kousuke
    Igawa, Tsukasa
    Sasada, Tetsuro
    Itoh, Kyogo
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E18 - E18
  • [2] Phase II study of personalized peptide vaccination for standard therapy-resistant urothelial carcinoma patients
    Suekane, S.
    Noguchi, M.
    Moriya, F.
    Sasada, T.
    Matsueda, S.
    Itoh, K.
    Matsuoka, K.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E863 - U818
  • [3] Randomized phase II study of personalized peptide vaccination with cyclophosphamide pretreatment in refractory advanced biliary tract cancer patients
    Sasada, Tetsuro
    Yutani, Shigeru
    Matsueda, Satoko
    Shirahama, Takashi
    Yamada, Akira
    Itoh, Kyogo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR ADVANCED UROTHELIAL CARCINOMA PATIENTS WHO FAILED STANDARD TREATMENT
    Suekane, S.
    Noguchi, M.
    Moriya, F.
    Sasada, T.
    Yamada, A.
    Itoh, K.
    Matsuoka, K.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 210 - 211
  • [5] Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma
    Suekane, Shigetaka
    Ueda, Kousuke
    Nishihara, Kiyoaki
    Sasada, Tetsuro
    Yamashita, Takuto
    Koga, Noriko
    Yutani, Shigeru
    Shichijo, Shigeki
    Itoh, Kyogo
    Igawa, Tsukasa
    Noguchi, Masanori
    [J]. CANCER SCIENCE, 2017, 108 (12) : 2430 - 2437
  • [6] PHASE II STUDY OF PERSONALIZED PEPTIDE VACCINATION FOR CISPLATIN-BASED CHEMOTHERAPY RESISTANT ADVANCED UROTHELIAL CARCINOMA PATIENTS
    Suekane, Shigetaka
    Noguchi, Masanori
    Moriya, Fukuko
    Sasada, Tetsuro
    Matsuoka, Kei
    Itoh, Kyogo
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E213 - E213
  • [7] A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients
    Yutani, Shigeru
    Komatsu, Nobukazu
    Yoshitomi, Munehiro
    Matsueda, Satoko
    Yonemoto, Koji
    Mine, Takashi
    Noguchi, Masanori
    Ishihara, Yuki
    Yamada, Akira
    Itoh, Kyogo
    Sasada, Tetsuro
    [J]. ONCOLOGY REPORTS, 2013, 30 (03) : 1094 - 1100
  • [8] A phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy
    Beom, S-H.
    Lee, K-W.
    Cho, S-H.
    Park, Y. S.
    Kim, T. W.
    Lee, K. H.
    Jung, M.
    Shin, S. J.
    Ahn, J. B.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 190 - 190
  • [9] Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
    Takahashi, Ryuji
    Ishibashi, Yukinao
    Hiraoka, Koji
    Matsueda, Satoko
    Kawano, Kouichirou
    Kawahara, Akihiko
    Kage, Masayoshi
    Ohshima, Koichi
    Yamanaka, Ryuya
    Shichijo, Shigeki
    Shirouzu, Kazuo
    Itoh, Kyogo
    Sasada, Tetsuro
    [J]. CANCER SCIENCE, 2013, 104 (10) : 1285 - 1294
  • [10] Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy
    Rivera, E
    Holmes, FA
    Frye, D
    Valero, V
    Theriault, RL
    Booser, D
    Walters, R
    Buzdar, AU
    Dhingra, K
    Fraschini, G
    Hortobagyi, GN
    [J]. CANCER, 2000, 89 (11) : 2195 - 2201
12345